
High Quality GMP Factory OEM Canine Rabies Virus Vaccine for Pets Dogs

New Material Veterinary OEM Canine Rabies Virus Vaccine for Pets Dogs

New Material Veterinary Grade OEM Canine Rabies Virus Vaccine for Pets Dogs

I have found results from400+products and200+suppliers aboutRabies vaccine




Rabies vaccines for human or veterinary use must maintain a strict cold chain (typically 2°C to 8°C) throughout the entire supply chain. Buyers must verify the potency (IU/ml), which should meet WHO standards (≥2.5 IU per dose). Ensure the vaccine is produced using cell-culture or embryonated egg-based technology, as these are safer and more effective than older nerve-tissue vaccines.
Suppliers must possess a GMP (Good Manufacturing Practice) certificate and, ideally, WHO Prequalification for international procurement. For specific markets, check for CE marking (Europe) or FDA approval (USA). Documentation such as the Certificate of Analysis (CoA) and Product Registration License from the exporting country's health authority is non-negotiable.
Request clinical trial data or post-market surveillance reports to verify the seroconversion rate. Prioritize manufacturers who provide stability testing data under various temperature conditions. It is advisable to conduct a third-party audit of the manufacturing facility to ensure adherence to Quality Management Systems (ISO 13485).
Vaccines must be packed in validated thermal packaging (e.g., VIP insulation or EPS boxes) with calibrated temperature data loggers. The packaging should include freeze indicators to ensure the product was not exposed to sub-zero temperatures, which can denature the proteins and render the vaccine ineffective.
The biggest risk is Cold Chain Breach, which leads to total product loss. Additionally, regulatory rejection at customs due to incomplete health permits or counterfeit products are significant threats. Always use Verified Suppliers on Made-in-China.com who have a proven track record in pharmaceutical exports.
Avoid standard shipping; instead, use specialized cold-chain logistics providers. Negotiate for CIF (Cost, Insurance, and Freight) or DAP (Delivered at Place) terms where the seller retains responsibility for the integrity of the cold chain until it reaches a designated port or warehouse. Ensure insurance covers 'spoilage due to temperature excursion'.
Use Escrow services or Letters of Credit (L/C) that trigger payment only upon the presentation of a clean bill of lading and a temperature log report showing no excursions during transit. Never wire full payments upfront to unverified suppliers.
Many countries classify vaccines as strategic medical supplies, requiring specific Import Permits from the Ministry of Health. Be aware of export quotas in the supplier's country and ensure all HS Codes (typically 3002.20) are correctly declared to avoid lengthy customs delays that could jeopardize the cold chain.